Logo image of AGX

ARGAN INC (AGX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AGX - US04010E1091 - Common Stock

337.9 USD
+12.31 (+3.78%)
Last: 12/22/2025, 8:26:29 PM
337.9 USD
0 (0%)
After Hours: 12/22/2025, 8:26:29 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to AGX. AGX was compared to 54 industry peers in the Construction & Engineering industry. AGX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, AGX could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

AGX had positive earnings in the past year.
AGX had a positive operating cash flow in the past year.
In the past 5 years AGX has always been profitable.
Of the past 5 years AGX 4 years had a positive operating cash flow.
AGX Yearly Net Income VS EBIT VS OCF VS FCFAGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

The Return On Assets of AGX (11.41%) is better than 79.63% of its industry peers.
Looking at the Return On Equity, with a value of 28.57%, AGX is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
With an excellent Return On Invested Capital value of 19.85%, AGX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
AGX had an Average Return On Invested Capital over the past 3 years of 12.29%. This is significantly below the industry average of 18.23%.
The 3 year average ROIC (12.29%) for AGX is below the current ROIC(19.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.41%
ROE 28.57%
ROIC 19.85%
ROA(3y)7.46%
ROA(5y)6.65%
ROE(3y)15.73%
ROE(5y)13.27%
ROIC(3y)12.3%
ROIC(5y)10.65%
AGX Yearly ROA, ROE, ROICAGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 13.11%, AGX belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
AGX's Profit Margin has improved in the last couple of years.
AGX has a better Operating Margin (13.08%) than 85.19% of its industry peers.
In the last couple of years the Operating Margin of AGX has remained more or less at the same level.
AGX has a Gross Margin (19.20%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AGX has declined.
Industry RankSector Rank
OM 13.08%
PM (TTM) 13.11%
GM 19.2%
OM growth 3Y-0.64%
OM growth 5YN/A
PM growth 3Y9.24%
PM growth 5YN/A
GM growth 3Y-6.25%
GM growth 5YN/A
AGX Yearly Profit, Operating, Gross MarginsAGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so AGX is creating value.
The number of shares outstanding for AGX has been increased compared to 1 year ago.
The number of shares outstanding for AGX has been reduced compared to 5 years ago.
There is no outstanding debt for AGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AGX Yearly Shares OutstandingAGX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
AGX Yearly Total Debt VS Total AssetsAGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 6.60 indicates that AGX is not in any danger for bankruptcy at the moment.
AGX's Altman-Z score of 6.60 is amongst the best of the industry. AGX outperforms 85.19% of its industry peers.
There is no outstanding debt for AGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.6
ROIC/WACC1.86
WACC10.69%
AGX Yearly LT Debt VS Equity VS FCFAGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

AGX has a Current Ratio of 1.61. This is a normal value and indicates that AGX is financially healthy and should not expect problems in meeting its short term obligations.
AGX has a better Current ratio (1.61) than 79.63% of its industry peers.
A Quick Ratio of 1.60 indicates that AGX should not have too much problems paying its short term obligations.
The Quick ratio of AGX (1.60) is better than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.6
AGX Yearly Current Assets VS Current LiabilitesAGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.62% over the past year.
Measured over the past years, AGX shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.55% on average per year.
AGX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.49%.
Measured over the past years, AGX shows a very strong growth in Revenue. The Revenue has been growing by 29.61% on average per year.
EPS 1Y (TTM)77.62%
EPS 3Y36.55%
EPS 5YN/A
EPS Q2Q%8.5%
Revenue 1Y (TTM)13.49%
Revenue growth 3Y19.72%
Revenue growth 5Y29.61%
Sales Q2Q%-2.28%

3.2 Future

AGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.61% yearly.
The Revenue is expected to grow by 16.35% on average over the next years. This is quite good.
EPS Next Y29.49%
EPS Next 2Y24.35%
EPS Next 3Y26.61%
EPS Next 5YN/A
Revenue Next Year14.92%
Revenue Next 2Y16.58%
Revenue Next 3Y16.35%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AGX Yearly Revenue VS EstimatesAGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
AGX Yearly EPS VS EstimatesAGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

AGX is valuated quite expensively with a Price/Earnings ratio of 39.80.
AGX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.61, AGX is valued a bit more expensive.
With a Price/Forward Earnings ratio of 35.76, AGX can be considered very expensive at the moment.
AGX's Price/Forward Earnings is on the same level as the industry average.
AGX's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.01.
Industry RankSector Rank
PE 39.8
Fwd PE 35.76
AGX Price Earnings VS Forward Price EarningsAGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AGX is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, AGX is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.49
EV/EBITDA 29.59
AGX Per share dataAGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

AGX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AGX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as AGX's earnings are expected to grow with 26.61% in the coming years.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y24.35%
EPS Next 3Y26.61%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.64%, AGX is not a good candidate for dividend investing.
AGX's Dividend Yield is rather good when compared to the industry average which is at 0.41. AGX pays more dividend than 88.89% of the companies in the same industry.
With a Dividend Yield of 0.64, AGX pays less dividend than the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

On average, the dividend of AGX grows each year by 6.33%, which is quite nice.
AGX has paid a dividend for at least 10 years, which is a reliable track record.
AGX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.33%
Div Incr Years3
Div Non Decr Years3
AGX Yearly Dividends per shareAGX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

AGX pays out 18.60% of its income as dividend. This is a sustainable payout ratio.
The dividend of AGX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP18.6%
EPS Next 2Y24.35%
EPS Next 3Y26.61%
AGX Yearly Income VS Free CF VS DividendAGX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M
AGX Dividend Payout.AGX Dividend Payout, showing the Payout Ratio.AGX Dividend Payout.PayoutRetained Earnings

ARGAN INC

NYSE:AGX (12/22/2025, 8:26:29 PM)

After market: 337.9 0 (0%)

337.9

+12.31 (+3.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)12-04 2025-12-04/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners94.94%
Inst Owner Change2.33%
Ins Owners2.16%
Ins Owner Change-11.84%
Market Cap4.67B
Revenue(TTM)915.03M
Net Income(TTM)119.93M
Analysts74.29
Price Target348.64 (3.18%)
Short Float %4.48%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend1.36
Dividend Growth(5Y)6.33%
DP18.6%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-22 2026-01-22 (0.5)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28%
Min EPS beat(2)5.06%
Max EPS beat(2)50.93%
EPS beat(4)4
Avg EPS beat(4)48.32%
Min EPS beat(4)5.06%
Max EPS beat(4)91.97%
EPS beat(8)8
Avg EPS beat(8)39.01%
EPS beat(12)10
Avg EPS beat(12)22.12%
EPS beat(16)11
Avg EPS beat(16)15.04%
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-5.75%
Max Revenue beat(2)-3.52%
Revenue beat(4)1
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-5.75%
Max Revenue beat(4)16.54%
Revenue beat(8)5
Avg Revenue beat(8)8.64%
Revenue beat(12)5
Avg Revenue beat(12)4.13%
Revenue beat(16)6
Avg Revenue beat(16)2.22%
PT rev (1m)28.86%
PT rev (3m)38.1%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)-0.96%
EPS NY rev (1m)0%
EPS NY rev (3m)17.09%
Revenue NQ rev (1m)-4.45%
Revenue NQ rev (3m)-9.1%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 39.8
Fwd PE 35.76
P/S 5.1
P/FCF 16.49
P/OCF 16.26
P/B 11.12
P/tB 11.96
EV/EBITDA 29.59
EPS(TTM)8.49
EY2.51%
EPS(NY)9.45
Fwd EY2.8%
FCF(TTM)20.49
FCFY6.06%
OCF(TTM)20.78
OCFY6.15%
SpS66.26
BVpS30.39
TBVpS28.25
PEG (NY)1.35
PEG (5Y)N/A
Graham Number76.19
Profitability
Industry RankSector Rank
ROA 11.41%
ROE 28.57%
ROCE 27.77%
ROIC 19.85%
ROICexc N/A
ROICexgc N/A
OM 13.08%
PM (TTM) 13.11%
GM 19.2%
FCFM 30.93%
ROA(3y)7.46%
ROA(5y)6.65%
ROE(3y)15.73%
ROE(5y)13.27%
ROIC(3y)12.3%
ROIC(5y)10.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.2%
ROCE(5y)14.9%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.64%
OM growth 5YN/A
PM growth 3Y9.24%
PM growth 5YN/A
GM growth 3Y-6.25%
GM growth 5YN/A
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr -525.65%
Cap/Sales 0.44%
Interest Coverage 250
Cash Conversion 241.33%
Profit Quality 235.95%
Current Ratio 1.61
Quick Ratio 1.6
Altman-Z 6.6
F-Score7
WACC10.69%
ROIC/WACC1.86
Cap/Depr(3y)184.02%
Cap/Depr(5y)124.31%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.62%
EPS 3Y36.55%
EPS 5YN/A
EPS Q2Q%8.5%
EPS Next Y29.49%
EPS Next 2Y24.35%
EPS Next 3Y26.61%
EPS Next 5YN/A
Revenue 1Y (TTM)13.49%
Revenue growth 3Y19.72%
Revenue growth 5Y29.61%
Sales Q2Q%-2.28%
Revenue Next Year14.92%
Revenue Next 2Y16.58%
Revenue Next 3Y16.35%
Revenue Next 5YN/A
EBIT growth 1Y77.98%
EBIT growth 3Y18.95%
EBIT growth 5YN/A
EBIT Next Year86.72%
EBIT Next 3Y46.61%
EBIT Next 5YN/A
FCF growth 1Y114.02%
FCF growth 3Y81.34%
FCF growth 5Y28.2%
OCF growth 1Y112.35%
OCF growth 3Y80.71%
OCF growth 5Y25.61%

ARGAN INC / AGX FAQ

What is the fundamental rating for AGX stock?

ChartMill assigns a fundamental rating of 7 / 10 to AGX.


What is the valuation status of ARGAN INC (AGX) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARGAN INC (AGX). This can be considered as Fairly Valued.


How profitable is ARGAN INC (AGX) stock?

ARGAN INC (AGX) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for AGX stock?

The Price/Earnings (PE) ratio for ARGAN INC (AGX) is 39.8 and the Price/Book (PB) ratio is 11.12.


What is the financial health of ARGAN INC (AGX) stock?

The financial health rating of ARGAN INC (AGX) is 8 / 10.